MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 8251-8260 Newer>
Chemistry World
January 20, 2012
Sarah Houlton
Takeda slashes 10% of its workforce This represents about 10% of its workforce, and the cuts will be made in research, commercial and admin sections of the business. mark for My Articles 27 similar articles
The Motley Fool
January 20, 2012
Brian Orelli
19 Clinical Trials Aren't Enough The FDA rejects Bristol-Myers and AstraZeneca's dapagliflozin. mark for My Articles 130 similar articles
The Motley Fool
January 20, 2012
Seth Jayson
Intuitive Surgical Beats Up on Analysts Yet Again For the quarter ended Dec. 31, Intuitive Surgical beat expectations on revenues and beat expectations on earnings per share. mark for My Articles 649 similar articles
The Motley Fool
January 20, 2012
Seth Jayson
ZOLL Medical Beats Up on Analysts Yet Again For the quarter ended Jan. 1, ZOLL Medical met expectations on revenue and beat expectations on earnings per share. mark for My Articles 209 similar articles
The Motley Fool
January 20, 2012
Seth Jayson
UnitedHealth Group Beats Estimates Yet Again For the quarter ended Dec. 31, UnitedHealth Group met expectations on revenues and crushed expectations on earnings per share. mark for My Articles 688 similar articles
The Motley Fool
January 20, 2012
Dan Caplinger
Can Geron Recover in 2012? Let's look at this year's prospects for this company. mark for My Articles 53 similar articles
The Motley Fool
January 19, 2012
Sean Williams
No Vacancy: Workers Need Not Apply to This Sector Pharmaceutical and biotech layoffs are kicking into high gear. mark for My Articles 582 similar articles
The Motley Fool
January 19, 2012
Brian Orelli
New Hep C Data Impressive, but It's Not There Yet All-oral treatment still has a ways to go. mark for My Articles 284 similar articles
The Motley Fool
January 19, 2012
Anders Bylund
Can This Moat Still Stave Off Invading Hordes? A closer look at Intuitive Surgical's competition only confirms the thesis: this moat is safe as houses. mark for My Articles 146 similar articles
The Motley Fool
January 18, 2012
Brian Orelli
2 High-Flying Biotechs Face a New Hurdle The next number-one concern for Aeterna Zentaris' and Keryx's investors should be whether the drug passes its clinical trial. mark for My Articles 77 similar articles
<Older 8251-8260 Newer>    Return to current articles.